Note 1 - Revision of Previously Issued Consolidated Financial Statements - Impact of Correcting Errors (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2024	Mar. 31, 2023
Tax expense (benefit)	$ 75			$ 326			$ 446	$ 698
Net Income (Loss)	$ (35)	$ 1,229	$ (176)	$ 1,620	$ 847	$ 53	$ 1,018	$ 2,520
Basic Net Income (Loss) per Share (in dollars per share)	$ (0)			$ 0.11			$ 0.07	$ 0.17
Diluted Net Income (Loss) per Share (in dollars per share)	$ (0)			$ 0.11			$ 0.07	$ 0.17
Previously Reported [Member]
Tax expense (benefit)				$ 306				$ 602
Net Income (Loss)				$ 1,640				$ 2,616
Basic Net Income (Loss) per Share (in dollars per share)				$ 0.11				$ 0.18
Diluted Net Income (Loss) per Share (in dollars per share)				$ 0.11				$ 0.18
Revision of Prior Period, Adjustment [Member]
Tax expense (benefit)				$ 20				$ 96
Net Income (Loss)				$ (20)				$ (96)
Basic Net Income (Loss) per Share (in dollars per share)				$ (0)				$ (0.01)
Diluted Net Income (Loss) per Share (in dollars per share)				$ (0)				$ (0.01)